Samsung Medical Center Director Reappointed for Second Term
Seoul, Monday, 16 December 2024.
Dr. Park Seung-woo will continue leading Samsung Medical Center, praised for its global excellence in cancer care and digital innovation, starting January 1, 2025.
Leadership Achievement and Global Recognition
Under Dr. Park’s first term beginning in 2021, Samsung Medical Center (SMC) has achieved remarkable global recognition, particularly in cancer treatment. The hospital secured the third position worldwide for cancer treatment in Newsweek’s global hospital ranking, following only MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center [1][2]. As a general hospital competing against specialized cancer centers, this achievement particularly highlights SMC’s exceptional capabilities in comprehensive healthcare delivery [1].
Digital Healthcare Excellence
Dr. Park’s leadership has been marked by significant technological advancement and digital transformation. The hospital achieved the highest possible grade across four fields in the Healthcare Information and Management Systems Society’s (HIMSS) digital evaluation [1]. In recognition of these achievements, Dr. Park has been invited to deliver a keynote speech at HIMSS 2025 in Las Vegas [1][2]. Notably, SMC achieved a perfect score of 400 out of 400 in the Digital Health Indicator (DHI) survey, demonstrating its leadership in healthcare digitalization [1].
Expanding Healthcare Network and Innovation
The hospital has strengthened its position in the Korean healthcare landscape through strategic partnerships and network expansion. SMC serves as a key specialty care partner within Korea’s medical infrastructure [4], while maintaining focus on severe and challenging diseases [1]. Under Park’s direction, the hospital has successfully integrated artificial intelligence into medical practices and strengthened its critical care systems [1].
Future Vision and Sustainability
As SMC celebrates its 30th anniversary, Dr. Park’s reappointment signals a continued commitment to healthcare innovation. The hospital has demonstrated dedication to corporate social responsibility by establishing an ESG committee in 2021 and publishing annual ESG reports [1]. Dr. Park’s second term, effective January 1, 2025, will focus on further advancing the hospital’s position in future healthcare delivery [1][2].